ヒドロキシプロゲステロンカプロエート注射の世界市場2020-2026:1mL注入、5mL注入

QYResearchが発行した調査報告書(QYR20AP01073)
◆英語タイトル:Global Hydroxyprogesterone Caproate Injection Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP01073
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:113
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、ヒドロキシプロゲステロンカプロエート注射の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、ヒドロキシプロゲステロンカプロエート注射のグローバル市場動向、メーカー別競争状況、種類別市場規模(1mL注入、5mL注入)、用途別市場規模(病院注射、クリニック注射)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・ヒドロキシプロゲステロンカプロエート注射の種類別市場2015-2026:1mL注入、5mL注入
・ヒドロキシプロゲステロンカプロエート注射の用途別市場2015-2026:病院注射、クリニック注射
・ヒドロキシプロゲステロンカプロエート注射の北米市場分析
・ヒドロキシプロゲステロンカプロエート注射のアジア市場分析
・ヒドロキシプロゲステロンカプロエート注射の中南米市場分析
・ヒドロキシプロゲステロンカプロエート注射の中東・アフリカ市場分析
・関連企業情報:AMAG Pharmaceuticals、Mcguff Pharmaceuticals Inc、Aspen Oss B.V、American Regent, Inc.、Mylan Institutional
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.AMAG Pharmaceuticals is the leading manufacturer worldwide with the revenue market share of 83%, followed by Mcguff Pharmaceuticals Inc, Aspen Oss B.V, American Regent, Inc., and Mylan Institutional. North America and Europe are the two biggest selling regions, with the combined sales market share of 72%. In the forecast period, Asia-Pacific is expected to see the rapidest development.
In 2019, the global Hydroxyprogesterone Caproate Injection market size was US$ 255.2 million and is forecast to US$ 283.6 million in 2026, growing at a CAGR of 1.5% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Hydroxyprogesterone Caproate Injection.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Hydroxyprogesterone Caproate Injection market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Hydroxyprogesterone Caproate Injection market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Hydroxyprogesterone Caproate Injection market. Readers of the report can become informed about current and future trends of the global Hydroxyprogesterone Caproate Injection market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Hydroxyprogesterone Caproate Injection markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Hydroxyprogesterone Caproate Injection market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Hydroxyprogesterone Caproate Injection market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Hydroxyprogesterone Caproate Injection market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Hydroxyprogesterone Caproate Injection market is segmented into
1 mL Injection
5 mL Injection
The 5 mL Injection accounted for a larger market share of 52% in 2018, but it was projected to be exceeded by the 1mL one in 2025.

Market Segment by Application, the Hydroxyprogesterone Caproate Injection market is segmented into
Hospitals Injection
Clinics Injection
Hospital took a larger market share of 51% in 2018, but it was expected to be exceeded by the Clinic in 2025.

This report includes the following manufacturers; we can also add the other companies as you want.
AMAG Pharmaceuticals
Mcguff Pharmaceuticals Inc
Aspen Oss B.V
American Regent, Inc.
Mylan Institutional

The study objectives are:
To analyze and research the global Hydroxyprogesterone Caproate Injection status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Hydroxyprogesterone Caproate Injection manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Hydroxyprogesterone Caproate Injection are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Hydroxyprogesterone Caproate Injection Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Hydroxyprogesterone Caproate Injection Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 1 mL Injection
1.3.3 5 mL Injection
1.4 Market Segment by Application
1.4.1 Global Hydroxyprogesterone Caproate Injection Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Hospitals Injection
1.4.3 Clinics Injection
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Hydroxyprogesterone Caproate Injection Revenue (2015-2026)
2.1.1 Global Hydroxyprogesterone Caproate Injection Revenue (2015-2026)
2.1.2 Global Hydroxyprogesterone Caproate Injection Sales (2015-2026)
2.2 Hydroxyprogesterone Caproate Injection Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Hydroxyprogesterone Caproate Injection Sales by Regions (2015-2020)
2.2.2 Global Hydroxyprogesterone Caproate Injection Revenue by Regions (2015-2020)
2.3 Global Top Hydroxyprogesterone Caproate Injection Regions (Countries) Ranking by Market Size
2.4 Hydroxyprogesterone Caproate Injection Industry Trends
2.4.1 Hydroxyprogesterone Caproate Injection Market Top Trends
2.4.2 Market Drivers
2.4.3 Hydroxyprogesterone Caproate Injection Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Hydroxyprogesterone Caproate Injection Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Hydroxyprogesterone Caproate Injection Manufacturers by Sales (2015-2020)
3.1.1 Global Hydroxyprogesterone Caproate Injection Sales by Manufacturers (2015-2020)
3.1.2 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Hydroxyprogesterone Caproate Injection Sales in 2019
3.2 Global Top Manufacturers Hydroxyprogesterone Caproate Injection by Revenue
3.2.1 Global Hydroxyprogesterone Caproate Injection Revenue by Manufacturers (2015-2020)
3.2.2 Global Hydroxyprogesterone Caproate Injection Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hydroxyprogesterone Caproate Injection Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hydroxyprogesterone Caproate Injection as of 2019)
3.4 Global Hydroxyprogesterone Caproate Injection Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Hydroxyprogesterone Caproate Injection Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Hydroxyprogesterone Caproate Injection Market
3.7 Key Manufacturers Hydroxyprogesterone Caproate Injection Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Hydroxyprogesterone Caproate Injection Historic Market Review by Type (2015-2020)
4.1.2 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2015-2020)
4.1.3 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2015-2020)
4.1.4 Hydroxyprogesterone Caproate Injection Price by Type (2015-2020)
4.1 Global Hydroxyprogesterone Caproate Injection Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Hydroxyprogesterone Caproate Injection Sales Forecast by Type (2021-2026)
4.2.3 Global Hydroxyprogesterone Caproate Injection Revenue Forecast by Type (2021-2026)
4.2.4 Hydroxyprogesterone Caproate Injection Price Forecast by Type (2021-2026)

5 Global Hydroxyprogesterone Caproate Injection Market Size by Application
5.1 Global Hydroxyprogesterone Caproate Injection Historic Market Review by Application (2015-2020)
5.1.2 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2015-2020)
5.1.3 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2015-2020)
5.1.4 Hydroxyprogesterone Caproate Injection Price by Application (2015-2020)
5.2 Global Hydroxyprogesterone Caproate Injection Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Hydroxyprogesterone Caproate Injection Sales Forecast by Application (2021-2026)
5.2.3 Global Hydroxyprogesterone Caproate Injection Revenue Forecast by Application (2021-2026)
5.2.4 Hydroxyprogesterone Caproate Injection Price Forecast by Application (2021-2026)

6 North America
6.1 North America Hydroxyprogesterone Caproate Injection Breakdown Data by Company
6.2 North America Hydroxyprogesterone Caproate Injection Breakdown Data by Type
6.3 North America Hydroxyprogesterone Caproate Injection Breakdown Data by Application
6.4 North America Hydroxyprogesterone Caproate Injection Breakdown Data by Countries
6.4.1 North America Hydroxyprogesterone Caproate Injection Sales by Countries
6.4.2 North America Hydroxyprogesterone Caproate Injection Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Hydroxyprogesterone Caproate Injection Breakdown Data by Company
7.2 Europe Hydroxyprogesterone Caproate Injection Breakdown Data by Type
7.3 Europe Hydroxyprogesterone Caproate Injection Breakdown Data by Application
7.4 Europe Hydroxyprogesterone Caproate Injection Breakdown Data by Countries
7.4.1 Europe Hydroxyprogesterone Caproate Injection Sales by Countries
7.4.2 Europe Hydroxyprogesterone Caproate Injection Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Hydroxyprogesterone Caproate Injection Breakdown Data by Company
8.2 Asia Pacific Hydroxyprogesterone Caproate Injection Breakdown Data by Type
8.3 Asia Pacific Hydroxyprogesterone Caproate Injection Breakdown Data by Application
8.4 Asia Pacific Hydroxyprogesterone Caproate Injection Breakdown Data by Regions
8.4.1 Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Regions
8.4.2 Asia Pacific Hydroxyprogesterone Caproate Injection Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Hydroxyprogesterone Caproate Injection Breakdown Data by Company
9.2 Latin America Hydroxyprogesterone Caproate Injection Breakdown Data by Type
9.3 Latin America Hydroxyprogesterone Caproate Injection Breakdown Data by Application
9.4 Latin America Hydroxyprogesterone Caproate Injection Breakdown Data by Countries
9.4.1 Latin America Hydroxyprogesterone Caproate Injection Sales by Countries
9.4.2 Latin America Hydroxyprogesterone Caproate Injection Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Hydroxyprogesterone Caproate Injection Breakdown Data by Type
10.2 Middle East and Africa Hydroxyprogesterone Caproate Injection Breakdown Data by Application
10.3 Middle East and Africa Hydroxyprogesterone Caproate Injection Breakdown Data by Countries
10.3.1 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Countries
10.3.2 Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 AMAG Pharmaceuticals
11.1.1 AMAG Pharmaceuticals Corporation Information
11.1.2 AMAG Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.1.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Products and Services
11.1.5 AMAG Pharmaceuticals SWOT Analysis
11.1.6 AMAG Pharmaceuticals Recent Developments
11.2 Mcguff Pharmaceuticals Inc
11.2.1 Mcguff Pharmaceuticals Inc Corporation Information
11.2.2 Mcguff Pharmaceuticals Inc Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Products and Services
11.2.5 Mcguff Pharmaceuticals Inc SWOT Analysis
11.2.6 Mcguff Pharmaceuticals Inc Recent Developments
11.3 Aspen Oss B.V
11.3.1 Aspen Oss B.V Corporation Information
11.3.2 Aspen Oss B.V Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Products and Services
11.3.5 Aspen Oss B.V SWOT Analysis
11.3.6 Aspen Oss B.V Recent Developments
11.4 American Regent, Inc.
11.4.1 American Regent, Inc. Corporation Information
11.4.2 American Regent, Inc. Business Overview and Total Revenue (2019 VS 2018)
11.4.3 American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 American Regent, Inc. Hydroxyprogesterone Caproate Injection Products and Services
11.4.5 American Regent, Inc. SWOT Analysis
11.4.6 American Regent, Inc. Recent Developments
11.5 Mylan Institutional
11.5.1 Mylan Institutional Corporation Information
11.5.2 Mylan Institutional Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Mylan Institutional Hydroxyprogesterone Caproate Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Mylan Institutional Hydroxyprogesterone Caproate Injection Products and Services
11.5.5 Mylan Institutional SWOT Analysis
11.5.6 Mylan Institutional Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Hydroxyprogesterone Caproate Injection Sales Channels
12.2.2 Hydroxyprogesterone Caproate Injection Distributors
12.3 Hydroxyprogesterone Caproate Injection Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Hydroxyprogesterone Caproate Injection Sales Forecast (2021-2026)
13.1.1 Global Hydroxyprogesterone Caproate Injection Sales Forecast by Regions (2021-2026)
13.1.2 Global Hydroxyprogesterone Caproate Injection Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Hydroxyprogesterone Caproate Injection Sales Forecast (2021-2026)
13.2.2 North America Hydroxyprogesterone Caproate Injection Revenue Forecast (2021-2026)
13.2.3 North America Hydroxyprogesterone Caproate Injection Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Hydroxyprogesterone Caproate Injection Sales Forecast (2021-2026)
13.3.2 Europe Hydroxyprogesterone Caproate Injection Revenue Forecast (2021-2026)
13.3.3 Europe Hydroxyprogesterone Caproate Injection Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Hydroxyprogesterone Caproate Injection Sales Forecast (2021-2026)
13.4.2 Asia Pacific Hydroxyprogesterone Caproate Injection Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Hydroxyprogesterone Caproate Injection Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Hydroxyprogesterone Caproate Injection Sales Forecast (2021-2026)
13.5.2 Latin America Hydroxyprogesterone Caproate Injection Revenue Forecast (2021-2026)
13.5.3 Latin America Hydroxyprogesterone Caproate Injection Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Hydroxyprogesterone Caproate Injection Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

AMAG Pharmaceuticals、Mcguff Pharmaceuticals Inc、Aspen Oss B.V、American Regent, Inc.、Mylan Institutional

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ ヒドロキシプロゲステロンカプロエート注射の世界市場2020-2026:1mL注入、5mL注入(Global Hydroxyprogesterone Caproate Injection Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。